Editorial Standards

Latest News Today maintains rigorous editorial standards. Our team verifies information from trusted sources and provides context to help readers understand complex stories.

Last Updated: Thursday, October 1, 2026 at 07:10 PM
Category: Id

Editor's Note

Latest News Today provides comprehensive coverage and analysis of breaking news stories. This article is part of our ongoing coverage of wbna41387702, bringing you verified information from trusted sources with added context and expert perspective.

Why This Matters: Understanding the full context of this story helps readers make informed decisions and stay updated on developments that impact our community.

MEDTOX Scientific Announces Fourth Quarter and Year-End Conference Call

ST. PAUL, Minn., Feb. 2, 2011 (GLOBE NEWSWIRE) -- MEDTOX Scientific, Inc. (Nasdaq:MTOX), announced today that it will hold a teleconference to discuss fourth quarter and year-end results on Thursday, February 10, at 9:30 a.m. Central Time (10:30 a.m. Eastern). During the conference call, the Company may discuss and answer questions concerning business and financial developments and trends. The Company's responses to questions, as well as other matters discussed during the conference call, may contain or constitute information that has not been disclosed previously. MEDTOX is scheduled to release financial results for the quarter and year-end at approximately 6:00 a.m. Central Time on February 10.

ST. PAUL, Minn., Feb. 2, 2011 (GLOBE NEWSWIRE) -- MEDTOX Scientific, Inc. (Nasdaq:MTOX), announced today that it will hold a teleconference to discuss fourth quarter and year-end results on Thursday, February 10, at 9:30 a.m. Central Time (10:30 a.m. Eastern). During the conference call, the Company may discuss and answer questions concerning business and financial developments and trends. The Company's responses to questions, as well as other matters discussed during the conference call, may contain or constitute information that has not been disclosed previously. MEDTOX is scheduled to release financial results for the quarter and year-end at approximately 6:00 a.m. Central Time on February 10.

To access the teleconference, dial (877) 852-6576 ten minutes before the scheduled start time on February 10. International callers may access the call by dialing (719) 325-4861. Callers should ask for the MEDTOX quarterly conference call, hosted by Dick Braun, president and CEO of MEDTOX. 

A simultaneous webcast of the conference call will be available on the MEDTOX website in the "investors" section at . An audio replay of the conference call will be available through February 17 by dialing (888) 203-1112, passcode # 5363992. International callers may access the replay at (719) 457-0820, with the same passcode # 5363992.

MEDTOX Scientific, Inc., headquartered in St. Paul, Minn., is a provider of high quality specialized laboratory testing services and on-site/point-of-collection testing (POCT) devices. The company also supports customers with complete logistics, data and program management services. MEDTOX is a leader in providing esoteric laboratory testing services to hospitals and laboratories nationwide. This includes both central laboratory and bio-analytical testing for pharmaceutical clinical trials. MEDTOX develops and manufactures diagnostic devices for quick and economical on-site/point-of-collection analysis for drugs-of-abuse, therapeutic drugs and biological and agricultural toxins and provides employment drug screening and occupational health testing. For more information, see .

The MEDTOX Scientific, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3264

CONTACT: Paula Perry (877) 715-7236